New horizons for antiviral drug discovery from virus-host protein interaction networks.

Archive ouverte

de Chassey, Benoît | Meyniel-Schicklin, Laurène | Aublin-Gex, Anne | André, Patrice | Lotteau, Vincent

Edité par CCSD ; Elsevier -

International audience. Viruses are recurrent socio economical and health problems each year worldwide. Current drugs are mainly directed against viral components and select resistant strains that urge the need to develop new antiviral therapeutics. High-throughput screening technologies now allow to draw comprehensive genome-wide maps of physical and genetic virus-host interactions. This has been done recently for several viruses such as HIV, HCV, DENV and FLUAV and revealed a wealth of potential antiviral cellular targets. Systems-level analysis of virus-host protein networks and subnetworks begins to uncover several specific points of intervention for a human centered drug development. We present here this new paradigm in antiviral drug discovery together with the first promising antiviral molecules.

Consulter en ligne

Suggestions

Du même auteur

Viruses and interactomes in translation.

Archive ouverte | Meyniel-Schicklin, Laurène | CCSD

International audience. A decade of high-throughput screenings for intraviral and virus-host protein-protein interactions led to the accumulation of data and to the development of theories on laws governing interact...

Genetic screens for the control of influenza virus replication: from meta-analysis to drug discovery.

Archive ouverte | de Chassey, Benoît | CCSD

International audience. Current anti-influenza virus drugs target two viral proteins and induce a selective pressure for the generation of drug resistant variants. This stresses the need for additional therapeutic s...

Virus-host interactomics: new insights and opportunities for antiviral drug discovery

Archive ouverte | Chassey, Benoit, De | CCSD

International audience. The current therapeutic arsenal against viral infections remains limited, with often poor efficacy and incomplete coverage, and appears inadequate to face the emergence of drug resistance. Ou...

Chargement des enrichissements...